Drug Profile
Research programme: apoptosis imaging agents - Aposense
Alternative Names: Molecular imaging agents - Aposense; Personalized Medicine - AposenseLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Aposense
- Class Diagnostic agents; Imaging agents; Small molecules
- Mechanism of Action Diagnostic imaging enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cancer; Neurological disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cancer in Israel (PO)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Neurological-disorders in Israel (PO)
- 28 Feb 2013 Preclinical trials in Cancer in Israel (unspecified route)